AHCYL1 and neoplasm: The tumor-promoting effects of AHCYL1 in NSCLC appear to rely heavily on its partnership with PREX2, as AHCYL1 knockdown specifically disrupts PREX2 GEF related signaling pathways in NSCLC but not in normal lung epithelia cell NL20 with low expression of PREX2.